| Literature DB >> 8690565 |
S Howard1, M Mugford, C Normand, D Elbourne, A Grant, D Field, A Johnson.
Abstract
A cost-effectiveness analysis is part of the U.K. ECMO Trial. In preparation for this analysis, existing evidence on the costs and effectiveness of neonatal ECMO was evaluated. ECMO appears to be more costly but may be more or less effective than conventional treatment. No case can be made for introducing ECMO before trial results are available.Mesh：
Year: 1996 PMID： 8690565 DOI： 10.1017/s0266462300009417
Source DB: PubMed Journal: Int J Technol Assess Health Care ISSN： 0266-4623 Impact factor: 2.188